Biotech

All Articles

3 biotechs attempt to trump the summer months warmth through shedding personnel

.As biotechs seek to switch a fresh webpage in August, at the very least 3 firms have shed workers i...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Professional venture capital agency venBio has elevated yet another half a billion dollars to acqui...

Otsuka pays $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has gotten Boston-based Jnana Therapies for $800 thousand so the Oriental biotech can g...

FibroGen lays off 75% people personnel as property flunks 2 even more tests

.FibroGen is drastically reorganizing its own business, giving up 75% of its own united state person...

Tracon relax full weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has chosen to unwind procedures weeks after an injectable invulnerable gate ...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on fallen short epilepsy medicine, promotes FDA manage

.Our experts already understand that Takeda is wishing to discover a path to the FDA for epilepsy me...

VBI Vaccinations apply for personal bankruptcy, seeks possession sale

.Immunology biotech VBI Vaccinations is drifting dangerously close to the defining moment, with prog...

Celldex anti-cKIT antitoxin decrease colonies in yet another phase 2 study

.It's challenging to muscle mass in on a room as very competitive as immunology, but Celldex Therape...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapies as well as a preclinical im...